Management, Body Systems, and Case Studies in COVID-19 describes the assessment and treatment of patients infected with the novel coronavirus that causes the varied symptoms of COVID-19. Detailing this multisystem disease and the organs and tissues affected, this volume features chapters on several body systems. Conditions affecting the respiratory, hematological, hepatobiliary, renal, gastrointestinal, nervous, musculoskeletal, and cardiovascular systems are addressed. The fundamental role of telemedicine during the pandemic is also discussed. This volume is relevant for all clinicians and…mehr
Management, Body Systems, and Case Studies in COVID-19 describes the assessment and treatment of patients infected with the novel coronavirus that causes the varied symptoms of COVID-19. Detailing this multisystem disease and the organs and tissues affected, this volume features chapters on several body systems. Conditions affecting the respiratory, hematological, hepatobiliary, renal, gastrointestinal, nervous, musculoskeletal, and cardiovascular systems are addressed. The fundamental role of telemedicine during the pandemic is also discussed. This volume is relevant for all clinicians and scientists working to ensure the best outcomes for patients with COVID-19.Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Section A: Introductory chapters and setting the scene 1. Hand hygiene strategies 2. Approved vaccines for the COVID-19 pandemic: Linking in future perspectives 3. Molecular methods for SARS-CoV-2 variant detection Section B: Management 4. Systematic patient assessment for acute respiratory tract ailments (SPARTA): A simple tool to improve outcomes from COVID-19 5. Point of care ultrasound for coronavirus disease 2019: The multiorgan approach to COVID-19 6. COVID-19 in patients with inflammatory bowel diseases: Features and guidelines 7. Management of COVID-19 and clinical nutrition 8. The management of head and neck cancer in COVID-19 9. The COVID-19 pandemic: Inventory management and allocation of personal protective equipment 10. Clinical management in the COVID-19 pandemic: Rheumatic disease 11. Managing migraines during the COVID-19 pandemic: An Italian experience 12. Managing acute ischemic stroke in the SARS-CoV-2 pandemic 13. Impact of the coronavirus disease 2019 pandemic on patients with hypertension 14. Neurosurgical trauma management during COVID-19 restrictions 15. The COVID-19 pandemic and management of weight gain: Implications for obesity 16. COVID-19 and the management of heart failure using telemedicine Section C: Guidelines for different treatment clinics 17. Guidelines for breast imaging in the COVID-19 pandemic 18. Vaccine-induced (immune) thrombotic thrombocytopenia (VITT): Diagnosis, guidelines, and reporting 19. Lung cancer in the era of COVID-19 20. Multisystem inflammatory syndrome in children/pediatric inflammatory multisystem syndrome: Clinical guidelines Section D: Impact on the respiratory system 21. Ground-glass nodules in the lungs of COVID-19 patients 22. Cardiothoracic imaging in patients affected by COVID-19 23. Cystic fibrosis and bronchial epithelial cells in SARS-CoV-2 infection 24. Biomechanics and mechanobiology of the lung parenchyma following SARS-CoV-2 infection 25. Long noncoding RNA profiling in respiratory specimens from COVID-19 patients 26. COVID-19 and acute pulmonary embolism 27. The usefulness of the alveolar-arteriolar gradient during the COVID-19 pandemic Section E: Effects on cardiovascular and hematological systems 28. Cardiac manifestations of COVID-19: An overview 29. Limb ischemia and COVID-19 30. Thrombosis and coagulopathy in COVID-19: A new narrative 31. COVID-19 myocarditis: Features of echocardiography 32. COVID-19 lockdown and impact on arrhythmias 33. Cardiometabolic disease and COVID-19: A new narrative 34. Postrecovery COVID-19 and interlinking diabetes and cardiovascular events 35. COVID-19 patients and extracorporeal membrane oxygenation 36. Sars-CoV-2 infection in different hematological patients Section F: Effects on body systems 37. Dermatological reactions associated with personal protective equipment use during the COVID-19 pandemic 38. Hemodialysis patients, effects of infections by SARS-CoV-2 and vaccine response 39. Coinfections with COVID-19: A focus on tuberculosis (TB) 40. Patients with autoimmune liver disease and the impact of Sars-COV-2 infection 41. COVID-19 severity and nonalcoholic fatty liver disease 42. Changes in obesity and diabetes severity during the COVID-19 pandemic at Virginia Commonwealth University health system 43. The diabetic patient and concomitant conditions rhinoorbital-cerebral mucormycosis and COVID-19 44. Tissue location of SARS-CoV-2 RNA: A focus on bone and implications for skeletal health 45. Linking between gastrointestinal tract effects of COVID-19 and tryptophan metabolism 46. Organ damage in SARS-CoV-2 infection in children: A focus on acute kidney injury 47. Obesity, COVID-19 severity, and mortality 48. Upper and lower gastrointestinal symptoms and manifestations of COVID-19 49. The COVID-19 survivors: Impact on skeletal muscle strength Section G: Case studies with mini review 50. A case report: COVID-19 meningoencephalitis and intracranial hemorrhage 51. Case study: Oral mucosal lesions in patients with COVID-19 52. Case study: COVID-19 pneumonia presented with cavitary lesions 53. Case study: Optic neuritis in SARS-CoV-2 infection Section H: Resources 54. Recommended resources relevant to the body systems involvement and management of COVID-19
Section A: Introductory chapters and setting the scene 1. Hand hygiene strategies 2. Approved vaccines for the COVID-19 pandemic: Linking in future perspectives 3. Molecular methods for SARS-CoV-2 variant detection Section B: Management 4. Systematic patient assessment for acute respiratory tract ailments (SPARTA): A simple tool to improve outcomes from COVID-19 5. Point of care ultrasound for coronavirus disease 2019: The multiorgan approach to COVID-19 6. COVID-19 in patients with inflammatory bowel diseases: Features and guidelines 7. Management of COVID-19 and clinical nutrition 8. The management of head and neck cancer in COVID-19 9. The COVID-19 pandemic: Inventory management and allocation of personal protective equipment 10. Clinical management in the COVID-19 pandemic: Rheumatic disease 11. Managing migraines during the COVID-19 pandemic: An Italian experience 12. Managing acute ischemic stroke in the SARS-CoV-2 pandemic 13. Impact of the coronavirus disease 2019 pandemic on patients with hypertension 14. Neurosurgical trauma management during COVID-19 restrictions 15. The COVID-19 pandemic and management of weight gain: Implications for obesity 16. COVID-19 and the management of heart failure using telemedicine Section C: Guidelines for different treatment clinics 17. Guidelines for breast imaging in the COVID-19 pandemic 18. Vaccine-induced (immune) thrombotic thrombocytopenia (VITT): Diagnosis, guidelines, and reporting 19. Lung cancer in the era of COVID-19 20. Multisystem inflammatory syndrome in children/pediatric inflammatory multisystem syndrome: Clinical guidelines Section D: Impact on the respiratory system 21. Ground-glass nodules in the lungs of COVID-19 patients 22. Cardiothoracic imaging in patients affected by COVID-19 23. Cystic fibrosis and bronchial epithelial cells in SARS-CoV-2 infection 24. Biomechanics and mechanobiology of the lung parenchyma following SARS-CoV-2 infection 25. Long noncoding RNA profiling in respiratory specimens from COVID-19 patients 26. COVID-19 and acute pulmonary embolism 27. The usefulness of the alveolar-arteriolar gradient during the COVID-19 pandemic Section E: Effects on cardiovascular and hematological systems 28. Cardiac manifestations of COVID-19: An overview 29. Limb ischemia and COVID-19 30. Thrombosis and coagulopathy in COVID-19: A new narrative 31. COVID-19 myocarditis: Features of echocardiography 32. COVID-19 lockdown and impact on arrhythmias 33. Cardiometabolic disease and COVID-19: A new narrative 34. Postrecovery COVID-19 and interlinking diabetes and cardiovascular events 35. COVID-19 patients and extracorporeal membrane oxygenation 36. Sars-CoV-2 infection in different hematological patients Section F: Effects on body systems 37. Dermatological reactions associated with personal protective equipment use during the COVID-19 pandemic 38. Hemodialysis patients, effects of infections by SARS-CoV-2 and vaccine response 39. Coinfections with COVID-19: A focus on tuberculosis (TB) 40. Patients with autoimmune liver disease and the impact of Sars-COV-2 infection 41. COVID-19 severity and nonalcoholic fatty liver disease 42. Changes in obesity and diabetes severity during the COVID-19 pandemic at Virginia Commonwealth University health system 43. The diabetic patient and concomitant conditions rhinoorbital-cerebral mucormycosis and COVID-19 44. Tissue location of SARS-CoV-2 RNA: A focus on bone and implications for skeletal health 45. Linking between gastrointestinal tract effects of COVID-19 and tryptophan metabolism 46. Organ damage in SARS-CoV-2 infection in children: A focus on acute kidney injury 47. Obesity, COVID-19 severity, and mortality 48. Upper and lower gastrointestinal symptoms and manifestations of COVID-19 49. The COVID-19 survivors: Impact on skeletal muscle strength Section G: Case studies with mini review 50. A case report: COVID-19 meningoencephalitis and intracranial hemorrhage 51. Case study: Oral mucosal lesions in patients with COVID-19 52. Case study: COVID-19 pneumonia presented with cavitary lesions 53. Case study: Optic neuritis in SARS-CoV-2 infection Section H: Resources 54. Recommended resources relevant to the body systems involvement and management of COVID-19
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
